The table below shows BIOGEN INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$2.20B
$2.88B
$1.55B
$1.38B
$3.64B
$4.23B
Capital expenditure
$153.80M
$153.70M
$277.00M
$240.30M
$258.10M
$424.80M
Investing cash flow
-$1.37B
-$799.20M
-$4.10B
$1.58B
-$563.70M
-$608.60M
Dividends paid
-
-
-
-
-
-
BIIB operating cash flow (10-K history)
BIOGEN INC. reported operating cash flow of $2.20B for fiscal year 2025. That is down 23.3% from $2.88B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $4.59B (FY 2016) to $2.20B. Figures come from the company's audited annual reports as filed with the SEC.
